Nicholas Investment Partners LP acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,520 shares of the company’s stock, valued at approximately $1,700,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Glenmede Trust Co. NA grew its stake in shares of Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after purchasing an additional 51 shares in the last quarter. Keating Financial Advisory Services Inc. acquired a new position in shares of Astera Labs during the second quarter valued at $25,000. Lido Advisors LLC raised its stake in shares of Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares in the last quarter. Goldstein Advisors LLC raised its stake in shares of Astera Labs by 5.8% during the fourth quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after purchasing an additional 88 shares in the last quarter. Finally, Johnson Financial Group Inc. acquired a new stake in Astera Labs in the second quarter worth about $43,000. 60.47% of the stock is currently owned by institutional investors.
Astera Labs Stock Down 2.6%
Shares of NASDAQ ALAB opened at $277.53 on Tuesday. The stock’s fifty day simple moving average is $350.46 and its 200 day simple moving average is $246.41. The stock has a market capitalization of $48.15 billion, a price-to-earnings ratio of 137.39 and a beta of 3.84. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48.
Insider Activity at Astera Labs
In other news, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief operating officer owned 1,119,038 shares in the company, valued at $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the sale, the general counsel owned 96,542 shares in the company, valued at $32,872,551. This represents a 6.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 419,244 shares of company stock valued at $163,135,169. Corporate insiders own 10.40% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on ALAB. Royal Bank Of Canada increased their price target on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Stifel Nicolaus upped their price objective on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. Bank of America raised their target price on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. Finally, Susquehanna lifted their target price on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $333.00.
Check Out Our Latest Stock Analysis on ALAB
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
